Faslodex (fulvestrant)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Injection Site Reaction (addition) Injection site related events including sciatica,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts